MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD

Neurology

Volumn 58, Issue 9, 2002, Pages 1381-1387

  Hernán, Miguel A ^a   Checkoway, H ^a   O'Brien, R ^a   Costa Mallen, P ^a   De Vivo, I ^a   Colditz, G A ^a   Hunter, D J ^a   Kelsey, K T ^a   Ascherio, A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NURSE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0037076476     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.9.1381     Document Type: Article

References (46)

1. The MPTP story. MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism
2. Cigarette smoking and protection from Parkinson's disease
3. Dopamine is a monoamine oxidase B substrate in man
4. Monoamine oxidase and oxidative stress at dopaminergic synapses
5. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
6. Inhibition of monoamine oxidase B in the brains of smokers
7. Association of a monoamine oxidase B allele with Parkinson's disease
8. An allelic association study of monoamine oxidase B in Parkinson's disease
9. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population
10. Genetic polymorphism of monoamine oxidase B and susceptibility to Parkinson's disease
11. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease
12. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease
13. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese
14. Parkinson's disease, MAOB, and smoking
15. Catecholamine metabolism: Basic aspects and clinical significance
16. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
17. No association between Parkinson's disease and low-activity alleles of catechol-Omethyltransferase
18. Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan
19. Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland
20. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease
21. High and low activity alleles of catechol-O-methyltransferase gene: Ethnic difference and possible association with Parkinson's disease
22. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
23. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease
24. An association between the allele coding for a low activity variant of catechol-O-methyl transferase and the risk of breast cancer
25. Prospective study of smoking, antioxidant intake, and lung cancer in middle-aged women
26. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women
27. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies
28. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles
29. Increased stress response and beta-phenylethamine in MAOB-deficient mice
30. The effect of age on the activity and molecular properties of human brain monoamine oxidase
31. Effect of deprenyl on the progression of disability in early Parkinson's disease
32. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease
33. The effect of deprenyl and levodopa on the progress of Parkinson's disease
34. Neurochemical perspectives to the function of monoamine oxidase
35. Monoamine oxidase B, smoking, and Parkinson's disease
36. Platelet monoamino oxidase-B activity in Parkinson's disease
37. Monoamine oxidase B and Parkinson's disease
38. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype
39. Enhancer sequences and the regulation of gene transcription
40. Organization of the human monoamine oxidase genes and long-range physical mapping around them
41. Identification of human monoamine oxidase (MAO) A and B gene promoters
42. Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease
43. Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease
44. An evaluation of old and new tests of heterogeneity in meta-analysis in epidemiologic research
45. HEpiMA. A software for the identification of heterogeneity in meta-analysis
46. Variability and validity of polymorphism association studies in Parkinson's disease